Search Results

Ki16425 25mg  | 98.1%

APEXBIO TECHNOLOGY LLC

LPA receptor antagonist GPCR/G protein|LPA Receptor

More Information Supplier Page

×

Ki16425

Ki16425 100mg  | 98.1%

APEXBIO TECHNOLOGY LLC

LPA receptor antagonist GPCR/G protein|LPA Receptor

More Information Supplier Page

×

Ki16425

Bendamustine HCl 5mg  | 99.74%

APEXBIO TECHNOLOGY LLC

Cytostatic agent for non-Hodgkin lymphomas Apoptosis|Apoptosis Inducers

More Information Supplier Page

×

Bendamustine HCl

Bendamustine HCl 10mg  | 99.74%

APEXBIO TECHNOLOGY LLC

Cytostatic agent for non-Hodgkin lymphomas Apoptosis|Apoptosis Inducers

More Information Supplier Page

×

Bendamustine HCl

Nu 6027 10mM (in 1mL DMSO)  | 98%

APEXBIO TECHNOLOGY LLC

ATR/CDK inhibitor, potent and selective Cell Cycle/Checkpoint|Cyclin-Dependent Kinases

More Information Supplier Page

×

Nu 6027

Nu 6027 5mg  | 98%

APEXBIO TECHNOLOGY LLC

ATR/CDK inhibitor, potent and selective Cell Cycle/Checkpoint|Cyclin-Dependent Kinases

More Information Supplier Page

×

Nu 6027

Nu 6027 10mg  | 98%

APEXBIO TECHNOLOGY LLC

ATR/CDK inhibitor, potent and selective Cell Cycle/Checkpoint|Cyclin-Dependent Kinases

More Information Supplier Page

×

Nu 6027

Bendamustine HCl 10mM (in 1mL DMSO)  | 99.74%

APEXBIO TECHNOLOGY LLC

Cytostatic agent for non-Hodgkin lymphomas Apoptosis|Apoptosis Inducers

More Information Supplier Page

×

Bendamustine HCl

SNS-032 (BMS-387032) 100mg  | 99.21%

APEXBIO TECHNOLOGY LLC

CDK inhibitor Cell Cycle/Checkpoint|Cyclin-Dependent Kinases

More Information Supplier Page

×

SNS-032 (BMS-387032)

SNS-032 (BMS-387032) 25mg  | 99.21%

APEXBIO TECHNOLOGY LLC

CDK inhibitor Cell Cycle/Checkpoint|Cyclin-Dependent Kinases

More Information Supplier Page

×

SNS-032 (BMS-387032)